JM, V., K, F., L, W., A, M., D, S., H, C., . . . C, B. (2023). Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: A report from The North American Mantle Cell Lymphoma Consortium. Journal of hematology & oncology, 16(1), 122. https://doi.org/10.1186/s13045-023-01520-7
Chicago Style (17th ed.) CitationJM, Vose, et al. "Integrative Analysis of Clinicopathological Features Defines Novel Prognostic Models for Mantle Cell Lymphoma in the Immunochemotherapy Era: A Report from The North American Mantle Cell Lymphoma Consortium." Journal of Hematology & Oncology 16, no. 1 (2023): 122. https://doi.org/10.1186/s13045-023-01520-7.
MLA (9th ed.) CitationJM, Vose, et al. "Integrative Analysis of Clinicopathological Features Defines Novel Prognostic Models for Mantle Cell Lymphoma in the Immunochemotherapy Era: A Report from The North American Mantle Cell Lymphoma Consortium." Journal of Hematology & Oncology, vol. 16, no. 1, 2023, p. 122, https://doi.org/10.1186/s13045-023-01520-7.
